Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Kota Kodama
Additive manufacturing, also known as 3D printing, has emerged as a transformative technology in the pharmaceutical industry. This article explores the recent breakthroughs in additive manufacturing and its future prospects in the pharmaceutical field. The advancements include personalized drug dosage forms, complex drug delivery systems, scaffold-based tissue engineering, and on-demand drug manufacturing. These breakthroughs offer opportunities for tailored medications, precise drug delivery, tissue regeneration, and decentralized drug production. The future implications encompass regulatory considerations, personalized medicine, drug discovery and formulation, and advancements in bio printing. While challenges remain, additive manufacturing in pharmaceuticals holds great potential to revolutionize drug development, enhance patient care, and reshape the healthcare landscape. Continued research, collaboration, and regulatory frameworks are vital to unlock the full capabilities of this technology and realize its promising future prospects.